Open-access Characterization of adverse reactions to benznidazole in patients with Chagas disease in the Federal District, Brazil

Abstract

INTRODUCTION:  Benznidazole is used for treating Chagas disease (CD). This cross-sectional study aimed to characterize the adverse drug reactions (ADRs) of benznidazole at a public hospital in Brazil’s Federal District.

METHODS:  Medical records were analyzed and ADRs were categorized by type, intensity, seriousness, and causality.

RESULTS:  Of the 62 patients who started benznidazole treatment for CD, 41 (66%) presented with 105 ADRs; 23 (37%) discontinued the treatment. Most reactions were classified as probable (81%), severe (63%), serious (67%), and dose-dependent (56%).

CONCLUSIONS:  The high incidence of ADRs because of treatment withdrawal revealed the need for safer alternatives for CD treatment.

Keywords: Chagas disease; Benznidazole; Drug-related side effects; Adverse reactions

location_on
Sociedade Brasileira de Medicina Tropical - SBMT Sociedade Brasileira de Medicina Tropical - SBMT, Núcleo de Medicina Tropical – UnB, Sala 43C – 70904-970, E-mails: rsbmt@uftm.edu.br | artes.rsbmt@gmail.com | sbmt@sbmt.org.br , WhatsApp: SBMT (61) 9.9192-6496, WhatsApp: RSBMT (34) 9.9996-5807 - Brasília - DF - Brazil
E-mail: rsbmt@uftm.edu.br
rss_feed Acompanhe os números deste periódico no seu leitor de RSS
Acessibilidade / Reportar erro